Like most other drugs, Auvelity can cause side effects. Hair loss was not reported in the drug’s studies, but it has been reported since the drug was made available on the market. Auvelity can ...
The FDA has cleared Auvelity (dextromethorphan/bupropion ... NMDA antagonist dextromethorphan is an ingredient found in cough syrups, while bupropion is an established antidepressant that was ...
Hosted on MSN1mon
BofA raises Axsome stock target on extended Auvelity exclusivityThe adjustment comes after Axsome announced a patent settlement regarding its antidepressant drug, Auvelity. The settlement terms grant a license to Teva Pharmaceuticals, allowing them to ...
Axsome grants Teva a license to sell generic Auvelity starting in 2038 or 2039, resolving all ongoing patent litigation. Axsome's Q4 and full-year 2024 Auvelity sales are expected at $92.6M and $ ...
Axsome had sued Teva for patent infringement when the generic drugmaker filed for approval of a knock-off version of Auvelity, a medicine for major depressive disorder that last year earned Axsome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback